Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection

BACKGROUND: At onset of coronavirus disease 2019 (COVID-19) pandemic, hydroxychloroquine (HCQ) was repurposed for treatment of patients based on reports that it had in vitro activity. The aim of this study was to find out if HCQ reduces number of days of hospitalization when given to patients with m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Med J Armed Forces India
Hauptverfasser: Gupta, Salil, Dixit, Prashant Kumar, Ghana, Parthasarathi, Abhisheka, Kumar, Khurana, Harshit, Jha, Vijoy Kumar, Mahapatra, Debasish, Goel, Jitesh, Ahmed, Safia, Varadaraj, G.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313076/
https://ncbi.nlm.nih.gov/pubmed/34334898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.02.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge